Tag:
salsalate
Latest Headlines
Latest Headlines
Catabasis lands $39M Series A for diabetes programs
Just days after raising its first tranche, Cambridge, MA-based Catabasis Pharmaceuticals announced this morning that it has completed a $39.6 million Series A venture round. The round, large for a
Researcher: old drug may offer weapon against diabetes
Back in the late 1990s, Harvard researcher Steven Shoelson stumbled on to some old evidence that the drug salsalate may be a cheap and effective therapy to use against diabetes. An article published
